Johnson & Johnson Vision News
Johnson & Johnson Vision News
Johnson & Johnson Vision Introduces New ACUVUE® OASYS MULTIFOCAL with PUPIL OPTIMIZED DESIGN and Expands the ACUVUE® OASYS Portfolio of Offerings for Patients with Presbyopia
- Newest member of the ACUVUE® OASYS Brand Family designed to deliver crisp, clear reliable vision at all distances, regardless of age or refractive error1.
- The new lens is designed for superior visual performance and a more precise fit∞1.
Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, introduces a new eye care option for patients with presbyopia: ACUVUE® OASYS MULTIFOCAL Contact Lenses with PUPIL OPTIMIZED DESIGN. The new lens is now available in the United States and Canada. ACUVUE® OASYS MULTIFOCAL Contact Lenses with PUPIL OPTIMIZED DESIGN expands the products from the ACUVUE® OASYS portfolio, which includes lenses unbeaten in comfort across 29 clinical trials§ and delivers parameter optimization at 100% vs. less than 2% for the leading competitor ×1. The ACUVUE® OASYS MULTIFOCAL is built on the ACUVUE® OASYS Two-Week platform. It includes the PUPIL OPTIMIZED DESIGN technology, used in the 1-DAY ACUVUE® MOIST MULTIFOCAL, that is designed for crisp, clear, reliable vision at all distances, enabling patients with presbyopia to see distant, intermediate and near objects1.
ACUVUE® OASYS MULTIFOCAL uniquely combines three technologies: PUPIL OPTIMIZED DESIGN, Hybrid Back Curve Technology and a Proprietary Embedded Wetting Agent to create a lens designed for performance and comfort1.
“This ACUVUE® OASYS MULTIFOCAL contact lens brings a long-awaited solution to patients with presbyopia who have been looking for continuous, clear and comfortable vision at all distances,” said Xiao-Yu Song, MD, PhD, Global Head of Research & Development, Johnson & Johnson Vision***.
Globally, 1.9 billion people have presbyopia, which is the gradual loss of the eyes' ability to focus on nearby objects. Presbyopia usually becomes noticeable for patients in their early to mid-40s and continues to worsen until around age 65 .
“The new ACUVUE® OASYS MULTIFOCAL lenses are a breakthrough for patients with presbyopia because instead of fitting the patient to the lens, we can fit the lens to the patient1,” said Susan J. Gromacki, OD, MS, FAAO, FSLS****. “Patients can be easily and quickly fitted, which is great given that this is a multifocal lens.”
Available in both daily disposables and reusables, ACUVUE® offers multifocal lenses that have the same design, parameters, and fit process across modalities, enabling eye care practitioners (ECPs) to offer a more personalized solution for patients∞1. ECPs fitting patients for the ACUVUE® OASYS MULTIFOCAL can also use the free ACUVUE® Fit Calculator to quickly and easily find the optimal trial lens power for patients.
***Dr. Xiao-Yu Song, MD, PhD is an employee of Johnson & Johnson Vision, Inc. with oversight of Research and Development for both the Surgical Vision and Vision Care organizations.
**The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopedics, vision, and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment.
¥Euromonitor International; Eyewear 2021 Edition; Value sales at RSP, all retails channels, 2019 data.
****Dr. Susan J. Gromacki is a paid consultant of Johnson & Johnson Vision, Inc.
∞Compared to prior JJV multifocal design; technology optimized for both the parameters of refractive error and add power for a multitude of viewing distances and light levels.
*Johnson & Johnson Vision represents the products and services of Johnson & Johnson Surgical Vision, Inc., Johnson & Johnson Vision Care, Inc., and the affiliates of both.
1 American Academy of Ophthalmology, “Global prevalence of presbyopia and vision impairment from uncorrected presbyopia,” (2018). https://www.aaojournal.org/article/S0161-6420(17)33797-1/pdf